CN Patent

CN107441045B — 用于递送Wnt信号通路抑制剂的脂质体制剂及其制备方法

Assigned to Curegenix Inc · Expires 2018-10-19 · 8y expired

What this patent protects

本文提供一种用于递送Wnt信号通路抑制剂的脂质体制剂，其包含脂质分子和Wnt信号通路抑制剂，其中，所述脂质体制剂通过如下步骤制备：(1)提供Wnt信号通路抑制剂的水溶液，并且提供脂质分子的醇溶液；(2)将所述Wnt信号通路抑制剂的水溶液与所述脂质分子的醇溶液混合；(3)除去醇溶剂，从而得到装载有Wnt信号通路抑制剂的脂质体制剂。

USPTO Abstract

本文提供一种用于递送Wnt信号通路抑制剂的脂质体制剂，其包含脂质分子和Wnt信号通路抑制剂，其中，所述脂质体制剂通过如下步骤制备：(1)提供Wnt信号通路抑制剂的水溶液，并且提供脂质分子的醇溶液；(2)将所述Wnt信号通路抑制剂的水溶液与所述脂质分子的醇溶液混合；(3)除去醇溶剂，从而得到装载有Wnt信号通路抑制剂的脂质体制剂。

Drugs covered by this patent

Patent Metadata

Patent number: CN107441045B
Jurisdiction: CN
Classification: —
Expires: 2018-10-19
Drug substance claim: No
Drug product claim: No
Assignee: Curegenix Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.